The Georgia Research Alliance (GRA) expands research and commercialization capacity in Georgia’s universities to launch new companies,
Business Model:
Revenue: $500M
Employees: 51-200
Address: 270 Peachtree Street NW
City: Atlanta
State: GA
Zip: 30303
Country: US
The Georgia Research Alliance (GRA) expands research and commercialization capacity in Georgia’s universities to launch new companies, create high-value jobs and transform lives. Since its formation in 1990, GRA has leveraged over $600 million of state funding into: $2.6 billion of direct federal and private investment in Georgia 150+ newly launched companies 6,000+ high-skill, high-value jobs a portfolio of inventions, processes and technologies that benefit humankind GRA is an independent nonprofit (501c3) organization closely aligned with Georgia’s Department of Economic Development and works with the following partner universities: University of Georgia, Georgia Regents University, Emory University, Clark Atlanta University, Georgia Institute of Technology, Georgia State University, Mercer University and Morehouse School of Medicine.
Contact Phone:
+14043329770
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2016 | RePredix | Grant | 44k |
11/2008 | Inhibikase Therapeutics | Grant | 55.6k |
1/2016 | Corami Therapeutics | Grant | 58.2k |
10/2014 | Abby Med | Grant | 110k |
2/2019 | Cognition Medical | Grant | 66k |
1/2011 | Whisper Communications | Grant | 48k |
4/2012 | Cambium Medical Technologies | Grant | 25k |
1/2019 | Neovaccine Strategies | Grant | 50k |
9/2013 | QUE Oncology | Grant | 119k |
1/2018 | Centizyme | Grant | 35.2k |
2/2013 | QUE Oncology | Grant | 25k |
10/2012 | QUE Oncology | Grant | 25k |
7/2014 | QUE Oncology | Grant | 98.9k |
5/2014 | NovAb | Grant | 50k |
5/2017 | Nutrivert | Grant | 23.8k |
12/2012 | NovAb | Grant | 25k |
11/2010 | NeurOp | Grant | 150k |
3/2005 | NeurOp | Grant | 50k |
11/2015 | TendoNova | Grant | 49.3k |
10/2011 | NeurOp | Grant | 100k |
9/2017 | NatGlycan | Grant | 25k |
8/2017 | TendoNova | Grant | 43.6k |
3/2019 | TendoNova | Grant | 36k |
1/2007 | Velocity Medical Solutions | Grant | 50k |
5/2014 | Cambium Medical Technologies | Grant | 60k |
12/2005 | Velocity Medical Solutions | Grant | 50k |
3/2019 | Sequegenics | Grant | 32.5k |
7/2007 | Velocity Medical Solutions | Grant | 100k |
7/2014 | CloudTags | Grant | 15k |
3/2017 | DIASYST Inc. | Grant | 50k |
9/2014 | AlphaStem | Grant | 82.7k |
7/2012 | AlphaStem | Grant | 4k |
3/2016 | DIASYST Inc. | Grant | 50k |
3/2014 | Sanguina | Grant | 25k |
2/2019 | Lucid Scientific | Grant | 26.4k |
4/2016 | NovAb | Grant | 100k |
4/2015 | LymphaTech | Seed Round | - |
5/2018 | PDx Scan | Grant | 17.5k |
5/2017 | Sanguina | Grant | 61k |
7/2016 | MoQuality | Grant | 275k |
10/2011 | Cambium Medical Technologies | Grant | 25k |
2/2013 | Sanguina | Grant | 13k |
4/2016 | Nyra Medical | Grant | 20k |
7/2014 | Nyra Medical | Grant | 52.3k |
4/2009 | NeurOp | Grant | 50k |
1/2012 | AKESOgen | Grant | 150k |
9/2013 | Behavioral Science Technologies | Grant | 22.8k |
2/2011 | AKESOgen | Grant | 50k |
10/2011 | Nyra Medical | Grant | 10k |
12/2014 | NovAb | Grant | 150k |
4/2012 | NovAb | Grant | 25k |
3/2018 | RePredix | Grant | 36k |
3/2020 | Aviabiotic | Grant | 0 |
8/2005 | NeurOp | Grant | 50k |
10/2011 | AKESOgen | Grant | 100k |
12/2016 | Covanos | Grant | 49.9k |
8/2018 | Centizyme | Grant | 10k |
1/2015 | CloudTags | Grant | 75k |
11/2022 | Nyra Medical | Series A | 20M |
10/2017 | Abby Med | Grant | 40.6k |
10/2009 | Inhibikase Therapeutics | Grant | 50k |
3/2017 | Urjanet | Series C | 0 |
9/2014 | Clearside Biomedical | Series B | 16M |
8/2019 | HAWA Therapeutics | Seed Round | 25k |
11/2022 | Nyra Medical | Series A | 0 |
11/2018 | Antios Therapeutics | Series A | 0 |
8/2019 | Pyrefin | Grant | 52.6k |
12/2006 | Velocity Medical Solutions | Grant | 25k |
11/2017 | Centizyme | Grant | 10k |
2/2017 | Sophia Bioscience | Grant | 59.2k |
4/2018 | BioPace | Grant | 54.5k |
7/2017 | RePredix | Grant | 25k |
8/2019 | Proxime | Grant | 40.1k |
2/2018 | Proxime | Grant | 27k |
2/2019 | Aviabiotic | Grant | 30k |
11/2019 | PNP Therapeutics | Grant | 50k |
11/2011 | Metaclipse Therapeutics | Grant | 25k |
9/2008 | Inhibikase Therapeutics | Grant | 25k |
2/2018 | Oncospherix | Grant | 22.4k |
4/2019 | Oncospherix | Grant | 41.6k |
1/2012 | Nyra Medical | Grant | 25k |
7/2017 | NanoV Therapeutics | Grant | 24.8k |
1/2019 | Migra Therapeutics | Grant | 51.7k |
3/2014 | AngioCloud | Grant | 54.4k |
2/2020 | Focused Cryo | Grant | 0 |
3/2020 | Neovaccine Strategies | Grant | 0 |
2/2020 | Focused Cryo | Grant | 0 |
9/2016 | Nyra Medical | Grant | 74.9k |
1/2020 | Nyra Medical | Grant | 0 |
7/2010 | Inhibikase Therapeutics | Grant | 150k |
11/2008 | Inhibikase Therapeutics | Grant | 25k |
8/2016 | CellectCell | Grant | - |
10/2015 | CellectCell | Grant | - |
7/2010 | Iconic Therapeutics | Grant | 100k |
12/2019 | Focused Cryo | Grant | 0 |
11/2017 | Covanos | Grant | 39k |
12/2015 | Covanos | Grant | 80.5k |
3/2018 | Covanos | Grant | 40k |
6/2016 | MicroBplex | Grant | 100k |
7/2018 | BioPace | Grant | 105.2k |
2/2018 | Cognition Medical | Grant | 84k |
11/2015 | Accuitis | Seed Round | 0 |
5/2014 | MicroBplex | Grant | 73k |
7/2012 | MicroBplex | Grant | 25k |
9/2014 | RSV NewCo | Grant | 50k |
3/2016 | Sequegenics | Grant | 47.5k |
9/2017 | MicroBplex | Grant | 50.7k |
3/2018 | Migra Therapeutics | Grant | 35.8k |
3/2014 | Abby Med | Grant | 34k |
7/2012 | Sanguina | Grant | 25k |
12/2016 | Neurotrack | Grant | 800k |
4/2010 | Iconic Therapeutics | Grant | 150k |
1/2016 | Codoxo | Grant | 0 |
1/2010 | Iconic Therapeutics | Grant | 50k |
7/2019 | Kodikaz Therapeutic Solutions | Grant | 50k |
4/2017 | Corami Therapeutics | Grant | 29.9k |
10/2017 | Corami Therapeutics | Grant | 41.9k |
5/2015 | Corami Therapeutics | Grant | 11.8k |
1/2020 | BioData Consortium | Grant | 20k |
7/2019 | BioData Consortium | Grant | 25k |
3/2017 | Sequegenics | Grant | 65k |
9/2011 | Inhibikase Therapeutics | Grant | 100k |
8/2009 | Iconic Therapeutics | Grant | 48k |
9/2006 | Velocity Medical Solutions | Grant | 50k |
7/2019 | Lucid Scientific | Grant | 58.5k |
9/2017 | Reservoir | Grant | 25k |
3/2016 | Sanguina | Grant | 81k |
7/2015 | QUE Oncology | Grant | 150k |
11/2015 | QUE Oncology | Grant | 100k |
9/2006 | NeurOp | Grant | 25k |
6/2018 | Lucid Scientific | Grant | 23.9k |
1/2011 | AKESOgen | Grant | 50k |
12/2016 | NatGlycan | Grant | 25k |
7/2012 | Metaclipse Therapeutics | Grant | 57.5k |
4/2012 | Metaclipse Therapeutics | Grant | 42k |
11/2010 | Metaclipse Therapeutics | Grant | 25k |
6/2016 | DIASYST Inc. | Grant | 50k |
6/2011 | LiquidText | Grant | - |
6/2017 | Covanos | Grant | 75k |
1/2019 | DIASYST Inc. | Grant | 50k |
3/2020 | AngioCloud | Grant | 34.3k |
2/2022 | EarliTec Diagnostics | Series A | 19.5M |
1/2019 | MapHabit | Grant | 48.4k |
8/2021 | TendoNova | Seed Round | 250k |
9/2019 | TendoNova | Grant | 69k |
10/2018 | MapHabit | Grant | 58.5k |
11/2013 | MedShape | Seed Round | - |
5/2015 | MetCure Therapeutics | Grant | - |
12/2008 | Velocity Medical Solutions | Grant | 150k |
7/2018 | PNP Therapeutics | Grant | 50k |
1/2018 | Celtaxsys | Series E | - |
6/2018 | Oncospherix | Grant | 53.4k |
2/2019 | Pyrefin | Grant | 48.1k |
3/2019 | Abby Med | Grant | 50.6k |
6/2017 | BioPace | Grant | 30.3k |
8/2009 | Inhibikase Therapeutics | Grant | 50k |
2/2022 | EarliTec Diagnostics | Series A | 0 |
3/2020 | Aviabiotic | Grant | 0 |
3/2020 | AngioCloud | Grant | 0 |
3/2020 | Neovaccine Strategies | Grant | 0 |
2/2020 | Focused Cryo | Grant | 0 |
2/2020 | Focused Cryo | Grant | 0 |
1/2020 | Nyra Medical | Grant | 0 |
1/2020 | BioData Consortium | Grant | 0 |
12/2019 | Focused Cryo | Grant | 0 |
11/2019 | PNP Therapeutics | Grant | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|